NGS as the First-line Treatment in Advanced Biliary Tract Cancer

NCT04172402 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Advanced Biliary Tract Cancer

Interventions

DRUG: TS-1
DRUG: Gemcitabine
DRUG: Nivolumab

Sponsor

National Health Research Institutes, Taiwan

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]